ARTICLE | Company News
Diaxonhit, Boehringer Ingelheim deal
September 9, 2013 7:00 AM UTC
Boehringer Ingelheim partnered with Diaxonhit to discover and characterize splice variants with Diaxonhit's SpliceArray discovery platform that have the potential to be therapeutic cancer targets. Boe...